01—Abstract
Summary
Summary of the 8-K filed August 6, 2024. Cited figures are marked; the original filing is the authoritative source.
Axon Enterprise, Inc. (AXON) has filed an 8-K on August 6, 2024, to announce its second quarter financial results for the period ended June 30, 2024.
The filing primarily incorporates by reference a shareholder letter containing detailed financial performance information, including statements of operations, balance sheets, cash flow, segment reporting, statistical measures, and reconciliations of GAAP to non-GAAP financial measures. Investors should refer to the attached Exhibit 99.1 for the full suite of financial data and management's commentary on the quarter's performance. While this 8-K serves as notification of the earnings release, the detailed operational and financial insights, including specific revenue figures, profitability metrics, and forward-looking statements, are contained within the accompanying shareholder letter.
This letter will be crucial for understanding Axon's current financial health, growth drivers, and any significant developments that may impact future performance. Investors are encouraged to review Exhibit 99.1 thoroughly for a comprehensive understanding of Axon's Q2 2024 results.
02—Key points
Key Highlights
- Axon Enterprise, Inc. released its second quarter financial results for the period ending June 30, 2024, via an 8-K filing on August 6, 2024.
- The 8-K filing incorporates a detailed shareholder letter (Exhibit 99.1) containing the Company's financial performance.
- Key financial statements provided in Exhibit 99.1 include statements of operations, balance sheets, and cash flow information.
- Segment reporting is included in Exhibit 99.1, allowing for an analysis of performance across Axon's different business units.
- The filing includes statistical measures and reconciliations of GAAP to non-GAAP financial measures, providing a more nuanced view of financial performance.
- The information furnished under Item 2.02 is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
- Brittany Bagley, Chief Operating Officer and Chief Financial Officer, signed the report.
03—Questions
Frequently Asked Questions
Where can I find the detailed financial results for Axon's second quarter?
The detailed financial results, including the shareholder letter and financial statements, are provided as Exhibit 99.1 to this 8-K filing.
What specific financial information is included in the shareholder letter?
The shareholder letter (Exhibit 99.1) contains audited consolidated statements of operations, segment reporting, balance sheets, cash flow information, statistical measures, and reconciliations of GAAP to non-GAAP financial measures.
Is the information in this 8-K considered officially 'filed' for all purposes?
The information furnished under Item 2.02 of this report is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.
Who is responsible for this filing?
The report was signed by Brittany Bagley, Axon's Chief Operating Officer and Chief Financial Officer.
04—Continue